All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drjonesdc on TikTok · 73s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @drjonesdc's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Why AOD-9604 will always be my favorite fat loss peptide and I will continue to take it for as long
  2. 0:06as I can have access to it. It would do to my channel. Hi, I'm better Jones DC, a holistic obesity expert.
  3. 0:11Number one, AOD is extremely safe. When it comes to utilizing any sort of aid, I always want to use
  4. 0:15things that are as far from medications as possible that have the least amount of risk when it comes
  5. 0:20to peptides like AOD, basically side effectless. AOD is a fragment of the human growth hormone,
  6. 0:25but instead of the entire growth hormone, because I would not want to keep optimizing growth hormone
  7. 0:29all the time, it's just that fat loss portion. And the research is very clear on how powerful it is
  8. 0:34for mobilizing body fat. Well, I'm a big big proponent of long fasting. For me, after losing 100 pounds
  9. 0:40and struggling for a decade, it is the regular rounds of long fasting that have allowed me to keep my
  10. 0:44insulin resistance at bay and keep my body at a leaner physique. Well, AOD is something that I
  11. 0:50will always take specifically when I do my long fasting because it mobilizes the body fat. So not
  12. 0:55only does it make the fast less stressful for me and a little easier to do too as well, but it
  13. 0:59optimizes the fasting results. So I'm burning more fat. And it's just one of the many secrets
  14. 1:03that I do to maintaining a lean and muscular physique all year round. If you guys are curious
  15. 1:08about this, men and ladies, choose a text message. Get your hands on this powerful peptide. We'll see
  16. 1:12you later.

@drjonesdc's AOD peptide claims need more evidence

Lasting Weight Loss

TikTok creator

46.9K viewsWatch on TikTok

Quick answer

AOD-9604 is a synthetic growth hormone fragment studied primarily for its lipolytic properties in animal models, with the only Phase IIb human trial (Stier et al., 2013) finding no significant weight loss versus placebo over 24 weeks. It is not FDA-approved and is available only through compounding channels, meaning standardization and purity are not guaranteed. The creator combines it with extended fasting protocols, a combination that has no controlled human trial data to support additive or synergistic effects.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drjonesdc's AOD peptide claims need more evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@drjonesdc's AOD peptide claims need more evidence should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@drjonesdc's AOD peptide claims need more evidence" from Lasting Weight Loss. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: AOD-9604 is a synthetic growth hormone fragment studied primarily for its lipolytic properties in animal models, with the only Phase IIb human trial (Stier et al.

The reason this review is not generic is the source wording and the canonical claim label "peptides peptides on fyp aodpeptides foryou peptidetherapy fo." In this clip, the useful excerpt is: "Why AOD-9604 will always be my favorite fat loss peptide and I will continue to take it for as long as I can have access to it." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Animal models did show legitimate lipolytic activity (Heffernan et al.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

AOD-9604 is a synthetic growth hormone fragment studied primarily for its lipolytic properties in animal models, with the only Phase IIb human trial (Stier et al.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • AOD-9604 is a synthetic growth hormone fragment studied primarily for its lipolytic properties in animal models, with the only Phase IIb human trial (Stier et al., 2013) finding no significant weight loss versus placebo over 24 weeks. It is not FDA-approved and is available only through compounding channels, meaning standardization and purity are not guaranteed. The creator combines it with extended fasting protocols, a combination that has no controlled human trial data to support additive or synergistic effects.
  • The only Phase IIb human RCT on AOD-9604 (Stier et al., 2013) found no statistically significant weight loss compared to placebo over 24 weeks, which led its developer to halt the program.
  • Animal models did show legitimate lipolytic activity (Heffernan et al., 2001), but rodent fat metabolism and human fat metabolism are not the same thing, and that translation failed in trials.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The only Phase IIb human RCT on AOD-9604 (Stier et al., 2013) found no statistically significant weight loss compared to placebo over 24 weeks, which led its developer to halt the program.
  • Animal models did show legitimate lipolytic activity (Heffernan et al., 2001), but rodent fat metabolism and human fat metabolism are not the same thing, and that translation failed in trials.
  • AOD-9604 is not FDA-approved for any indication and is not classified as Generally Recognized as Safe. The FDA rejected a GRAS petition for it in 2014.
  • Because it does not significantly raise IGF-1, AOD-9604 avoids some of the concerns tied to full growth hormone therapy. That distinction is real and the creator gets credit for making it.
  • Compounded peptides have no federally enforced purity or dosing standards, meaning what you receive may not match what was studied in trials.
  • The fasting plus AOD combination has no controlled trial data. Extended fasting alone produces significant fat loss, making it impossible to know from personal experience what AOD is adding.
  • Soliciting patients via text message after a TikTok pitch for an unregulated compound raises serious questions about the prescribing and oversight process that viewers should ask about before engaging.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drjonesdc actually say?

The creator, who identifies as a holistic obesity expert and chiropractor, made several specific claims about AOD-9604: that it is "basically side effectless," that "the research is very clear on how powerful it is for mobilizing body fat," and that it works synergistically with extended fasting to enhance fat burning. They also described it as a fragment of human growth hormone that isolates only the "fat loss portion." The video ends with a direct pitch to text the creator for access to the peptide.

These are not vague wellness gestures. These are specific efficacy and safety claims directed at 46,000-plus viewers, many of whom may have no clinical supervision. That framing deserves scrutiny.

Does the science back this up?

Partially, but the creator significantly overstates the human evidence. AOD-9604 is indeed a synthetic fragment of human growth hormone, specifically the C-terminal region (amino acids 176-191), and early animal studies were genuinely promising. The problem is that the human data never caught up.

In rodent models, AOD-9604 demonstrated lipolytic activity and reduced adipose tissue without triggering insulin resistance, which is what made it interesting in the first place (Heffernan et al., 2001, American Journal of Physiology). However, a Phase IIb clinical trial in obese adults published by Stier et al. (2013) in the Obesity Research and Clinical Practice journal found no statistically significant weight loss compared to placebo over 24 weeks. The drug's developer, Metabolic Pharmaceuticals, halted further development after these results. Saying "the research is very clear on how powerful it is" is not accurate. The research is actually pretty clear that it did not work in human trials at the doses tested.

On the safety side, the creator is on slightly firmer ground. AOD-9604 has not shown the IGF-1 elevation concerns associated with full growth hormone therapy, and the trials did not flag serious adverse events. But "basically side effectless" is a marketing phrase, not a clinical finding, and long-term human safety data simply does not exist.

What did they get wrong (or right)?

Let's give credit where it is due. The creator is correct that AOD-9604 is structurally distinct from full growth hormone and does not carry the same IGF-1-driven risks, including potential proliferative effects. That distinction matters and is often glossed over in peptide content. They are also not wrong that it has a relatively benign short-term safety profile based on the clinical trial data we have.

What they got wrong is the efficacy claim. Saying "the research is very clear" when the only adequately powered human RCT showed no significant effect over placebo is misleading. The animal data is real but it does not translate cleanly to humans, and that failure point is kind of important when you are recommending people text you for access to the compound.

The fasting synergy claim, that AOD enhances fat mobilization during extended fasts, is plausible in theory given its proposed mechanism, but there is no controlled human trial testing this specific combination. It is anecdote dressed up as mechanism.

What should you actually know?

AOD-9604 exists in a complicated regulatory space. The FDA rejected a Generally Recognized as Safe (GRAS) designation for it as a food ingredient in 2014. It is not FDA-approved for any indication. It is currently available through compounding pharmacies in the United States, which means quality, purity, and dosing consistency vary significantly between suppliers.

The creator's personal story, losing 100 pounds, is compelling and likely genuine. But personal success stories cannot confirm that a specific compound is doing what you think it is doing, especially when combined with long fasting protocols that independently produce significant fat loss. Isolating AOD's contribution without a control condition is not possible through self-experimentation.

If you are considering any unscheduled peptide for weight management, that conversation belongs with a licensed clinician who can review your full metabolic picture, not a text message exchange prompted by a TikTok video.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Lasting Weight Loss · TikTok creator

46.9K views on this video

PEPTIDES ON 🔝 #fyp #aodpeptides #foryou #peptidetherapy #foryoupage #aod #fypシ #drjones #xybca #advice

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the only phase iib human rct on aod-9604 (stier et?

The only Phase IIb human RCT on AOD-9604 (Stier et al., 2013) found no statistically significant weight loss compared to placebo over 24 weeks, which led its developer to halt the program.

What does the video say about animal models did show legitimate lipolytic activity (heffernan et al.,?

Animal models did show legitimate lipolytic activity (Heffernan et al., 2001), but rodent fat metabolism and human fat metabolism are not the same thing, and that translation failed in trials.

What does the video say about aod-9604?

AOD-9604 is not FDA-approved for any indication and is not classified as Generally Recognized as Safe. The FDA rejected a GRAS petition for it in 2014.

What does the video say about because it does not significantly raise igf-1, aod-9604 avoids some?

Because it does not significantly raise IGF-1, AOD-9604 avoids some of the concerns tied to full growth hormone therapy. That distinction is real and the creator gets credit for making it.

What does the video say about compounded peptides have no federally enforced purity?

Compounded peptides have no federally enforced purity or dosing standards, meaning what you receive may not match what was studied in trials.

What does the video say about the fasting plus aod combination has no controlled trial data.?

The fasting plus AOD combination has no controlled trial data. Extended fasting alone produces significant fat loss, making it impossible to know from personal experience what AOD is adding.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Lasting Weight Loss, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.